Self-Rectifying Nanotubes for Safe Mitochondrial Uncoupling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current mitochondrial uncouplers, such as 2,4-DNP, are toxic due to their inability to control the uncoupling process, leading to a drop in ATP production and potential cell death, necessitating the development of safe and controllable methods to separate mitochondrial respiration from ATP production.
Innovation Solution
Nanotubes are designed to act as self-rectifying proton channels that only conduct protons when a specific mitochondrial membrane potential is reached, ensuring safe uncoupling by automatically shutting down when an unsafe potential is achieved, thereby controlling the uncoupling process and preventing toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical uncouplers are used to increase basal metabolism, then weight loss is promoted, but toxicity increases due to uncontrolled uncoupling
Solution Approach 1:
The patent changes the physical parameters of the uncoupling agent by using nanotubes with specific dimensions (length 10-100 nm, diameter 1-10 nm) and controlled proton conductance properties. These parameter changes allow the nanotubes to function as uncouplers while maintaining safety through automatic shutdown at unsafe potentials, resolving the contradiction between metabolic effectiveness and toxicity.
Solution Approach 2:
The nanotubes are designed to be self-regulating, automatically shutting down when unsafe mitochondrial membrane potentials are reached. This self-service mechanism eliminates the need for external control systems and prevents toxicity without compromising the ability to promote weight loss through increased basal metabolism.
2Productivity
If mitochondrial uncoupling is increased to promote weight loss, then metabolism increases, but ATP production drops below safe levels
Solution Approach 1:
The nanotubes incorporate a feedback mechanism where proton flow through the nanotube is automatically regulated by the mitochondrial membrane potential. When the potential drops below a safe threshold, the nanotube conductance decreases, preventing further uncoupling and protecting ATP production. This feedback loop resolves the contradiction between increasing metabolism and maintaining reliable ATP production.
3Productivity
If proton conductance is increased to uncouple mitochondria, then weight loss is enhanced, but control over uncoupling is lost
Solution Approach 1:
The nanotubes are designed to be self-regulating, automatically shutting down when unsafe mitochondrial membrane potentials are reached. This self-service mechanism eliminates the need for external control systems and prevents toxicity without compromising the ability to promote weight loss through increased basal metabolism.
Solution Approach 2:
The patent changes the physical parameters of the uncoupling agent by using nanotubes with specific dimensions (length 10-100 nm, diameter 1-10 nm) and controlled proton conductance properties. These parameter changes allow the nanotubes to function as uncouplers while maintaining safety through automatic shutdown at unsafe potentials, resolving the contradiction between metabolic effectiveness and toxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanotubes effectively increase basal metabolism, decrease reactive oxygen species, and reduce detrimental Ca2+ loading into mitochondria, promoting weight loss and treating various conditions without the toxicity associated with traditional uncouplers.
Implementation Method 1
Nanotubes are designed to act as self-rectifying proton channels that only conduct protons when a specific mitochondrial membrane potential is reached
Implementation Method 2
The translocation of protons from the matrix is due to the activity of the electron transport system, which takes electrons from a high energy state to a lower energy resulting in the reduction of oxygen to water, hence the term mitochondrial respiration since oxygen is consumed by this process. The energy released as electrons are taken from a high energy state to a lower energy state is used by this electron transport system to translocate (i.e., pump) the protons from the matrix to the inner membrane space resulting in a separation of charge (i.e., membrane potential) as well as a pH gradient across the inner membrane
Implementation Method 3
Nanotubes are designed to act as self-rectifying proton channels that only conduct protons when a specific mitochondrial membrane potential is reached, ensuring safe uncoupling by automatically shutting down when an unsafe potential is achieved
Implementation Method 4
The translocation of protons from the matrix is due to the activity of the electron transport system, which takes electrons from a high energy state to a lower energy resulting in the reduction of oxygen to water
Implementation Method 5
The translocation of protons from the matrix is due to the activity of the electron transport system, which takes electrons from a high energy state to a lower energy resulting in the reduction of oxygen to water
Implementation Method 6
The mitochondrial membrane potential is then 'coupled' to the controlled flow of protons back into the matrix through the ATP synthase which uses this flow to phosphorylate adenosine diphosphate ('ADP') to ATP
Data Source
AI summary
A method of uncoupling mitochondria in a subject including administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A method of decreasing reactive oxygen species and decreasing detrimental loading of Ca2+ into mitochondria is provided, including administering a pharmaceutically effective amount of nanotubes into the subject. A method of reducing weight, treating cancer, reducing the effects of traumatic brain injury, or reducing the effects of ageing, in a subject including administering a pharmaceutically effective amount of nanotubes into the subject is also provided.